SEC 8-K
SEC 8-K: Item 5.02, 5.03, 5.07, 9.01
Official SEC filing update. Items: 5.02, 5.03, 5.07, 9.01.
Item 5.02, 5.03, 5.07, 9.01Accession 0001193125-26-257593
Official SEC filings
CRISPR Therapeutics AG SEC Filings and Updates
A filing-level feed of official SEC EDGAR updates collected by Billiver. This page shows metadata and source links only; full filing text opens on SEC.gov.
CRISPR Therapeutics AG Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001193125-26-204188
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001193125-26-204147
SEC DEF 14A
SEC DEF 14A
Official SEC filing update.
DEF 14AAccession 0001193125-26-165158
SEC 8-K
SEC 8-K: Item 1.01, 2.03, 3.02, 9.01
Official SEC filing update. Items: 1.01, 2.03, 3.02, 9.01.
Item 1.01, 2.03, 3.02, 9.01Accession 0001193125-26-108333
SEC 8-K
SEC 8-K: Item 8.01, 9.01
Official SEC filing update. Items: 8.01, 9.01.
Item 8.01, 9.01Accession 0001193125-26-101073
SEC 10-K
SEC 10-K
Official SEC filing update.
10-KAccession 0001193125-26-048957
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001193125-26-048873
SEC 8-K
SEC 8-K: Item 8.01
Official SEC filing update. Items: 8.01.
Item 8.01Accession 0001193125-26-009880
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001193125-25-273337
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001193125-25-273329
SEC 8-K
SEC 8-K: Item 8.01, 9.01
Official SEC filing update. Items: 8.01, 9.01.
Item 8.01, 9.01Accession 0001193125-25-240282
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0000950170-25-102052
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0000950170-25-102027
SEC 8-K
SEC 8-K: Item 8.01
Official SEC filing update. Items: 8.01.
Item 8.01Accession 0000950170-25-090170
Source: SEC EDGAR · 15 filings
Informational only. Not investment advice.